The National Basketball Association (NBA) and its players' union have agreed that players will be tested for performance-enhancing substances but not for recreational substances such as cannabis when the 2019-2020 season begins again.
The NBA has suspended its season in the middle of the coronavirus pandemic and the league and the union are in the process of finalizing the details of the recovery, which includes locking themselves up for 3 months at Disney World in Florida.
Last Monday, the basketball league also rehabilitated Malik Monk, a Hornets player, who had been suspended indefinitely at the start of the season for violating the NBA's drug use policy.
While the NFL and MLB no longer suspend their players if they consume cannabis, the use of cannabis in the NBA regularly returns to the courts. In 2018, Michele Roberts, president of the players' union, said that the league "was exploring" medical exemptions for NBA players to use medical cannabis, but that federal law was an obstacle. At the time, Jeff Sessions was the Attorney General of the United States and Michele Roberts feared the arrest of players at airports at the request of the attorney.
Under the NBA-NBPA Collective Bargaining Agreement, players who test positive for performance-enhancing drugs will be suspended for 25 games for a first offense, 55 games for a second violation and are banned from the league for a minimum of two years for a third violation.
In the case of recreational substances, the penalties have so far been one internship in the event of a first offense, a $ 25,000 fine for the second, and 5 suspension games for the third. Any additional offenses added 5 suspension games to the previous penalty.
Players may have to take a drug test up to four times a season and twice during the off-season. The tests were suspended during containment.